Predictive Oncology Inc. POAI
Set alert
4.91 USD 0.00 0.00%
As of Apr 21, 3:59 PM ET
4.21 Day range 4.98
0.55 52-week range 3.76
- YTD
- +498.78%
- 1 year
- +520.73%
- Open
- 4.49
- Prev close
- 4.91
- Mkt cap
- 4.57M
- Vol
- 19.09K
- Avg vol
- 101.61K
- EPS
- -2.96
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.21
- High
- 4.98
- Forward P/E
- -5.72
- Beta
- 1.15
- Short ratio
- 1.26
- Inst. own
- 4.01%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.73052
- 200-d avg
- 1.21
- 1y target
- 0.00
2Y chart
Events in this range
- Mar 28, 2024Earnings: -0.85; estimate 0; surprise —%
- May 14, 2024Earnings: -1.04; estimate 0; surprise —%
- Aug 13, 2024Earnings: -0.68; estimate 0; surprise —%
- Aug 19, 2024Rating: HC Wainwright & Co. · — → Buy
- Nov 12, 2024Earnings: -0.36; estimate -0.32; surprise -12.5%
- Nov 15, 2024Downgrade: HC Wainwright & Co. · Buy → Neutral
- Sep 30, 2025Split: 1 for 15
Signals (83)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Dec 5, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 13, 2025 | 11 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| RSI: Oversold | Oct 23, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Sep 30, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 26, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| RSI: Overbought | Sep 22, 2025 | 1 year ago |
| RSI: Overbought | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 13, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| SMA: Bearish | May 22, 2025 | 1 year ago |
| SMA: Bullish | May 20, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| SMA: Bearish | May 7, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 25, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| SMA: Bearish | Apr 8, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Mar 25, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 25, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 20, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 18, 2025 | 1 year ago |
| RSI: Overbought | Feb 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 22, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 17, 2025 | 1 year ago |
| SMA: Bullish | Jan 3, 2025 | 1 year ago |
| RSI: Overbought | Jan 3, 2025 | 1 year ago |
| RSI: Overbought | Dec 27, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 26, 2024 | 1 year ago |
| SMA: Bullish | Dec 24, 2024 | 1 year ago |
| SMA: Bearish | Dec 19, 2024 | 1 year ago |
| SMA: Bullish | Dec 18, 2024 | 1 year ago |
| SMA: Bearish | Dec 17, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 16, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 26, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 14, 2024 | 1 year ago |
| SMA: Bullish | Nov 11, 2024 | 1 year ago |
| SMA: Bearish | Nov 8, 2024 | 1 year ago |
| SMA: Bullish | Nov 7, 2024 | 1 year ago |
| SMA: Bearish | Oct 29, 2024 | 2 years ago |
| SMA: Bullish | Oct 25, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 18, 2024 | 2 years ago |
| RSI: Oversold | Oct 17, 2024 | 2 years ago |
| RSI: Oversold | Oct 3, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 20, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 23, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 2, 2024 | 2 years ago |
| SMA: Bearish | Jul 30, 2024 | 2 years ago |
| SMA: Bullish | Jul 25, 2024 | 2 years ago |
| RSI: Overbought | Jul 25, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 2, 2024 | 2 years ago |
| RSI: Oversold | Jun 21, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | May 30, 2024 | 2 years ago |
| SMA: Bullish | May 28, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 25, 2024 | 2 years ago |
| RSI: Oversold | Apr 2, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 28, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 27, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 29, 2024 | 2 years ago |
| SMA: Bearish | Feb 28, 2024 | 2 years ago |
| RSI: Overbought | Feb 21, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 13, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 5, 2024 | 2 years ago |
Key statistics
- Market cap
- 4.57M
- Enterprise value
- 2.77M
- Trailing P/E
- 0.00
- Forward P/E
- -5.72
- PEG ratio
- 0.00
- Price / sales
- 2.62
- Price / book
- 0.34
- EPS (TTM)
- -2.96
- Beta
- 1.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.75M
- Revenue growth
- -43.10%
- Free cash flow
- -7.75M
- Total cash
- 5.33M
- Total debt
- 2.70M
- Return on equity
- -149.36%
- Shares outstanding
- 6.67M
- Short % of float
- 2.27%
- 50-day average
- 0.73052
- 200-day average
- 1.21
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
POAI Revenue — quarterly 3.62K
POAI Net income — quarterly -77.65M
POAI EPS — quarterly -107.25
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | -0.32 | -0.36 | -0.04 | -12.50% |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.68 | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | -1.04 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | 0.00 | -0.85 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | 0.00 | -0.78 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | -0.95 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | down | Buy | Neutral |
| Aug 19, 2024 | HC Wainwright & Co. | init | — | Buy |
About Predictive Oncology Inc.
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- predictive-oncology.com
News
- Predictive Oncology Q2 Earnings Call Highlights
- Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened
- Predictive Oncology Q4 Earnings Call Highlights
- Predictive Oncology (NASDAQ:POAI) Stock Passes Below Two Hundred Day Moving Average – Here’s What Happened
- Predictive Oncology (NASDAQ:POAI) versus Mitesco (OTCMKTS:MITI) Head-To-Head Comparison
- Financial Analysis: Predictive Oncology (NASDAQ:POAI) and Healthcare Triangle (NASDAQ:HCTI)
- Why RF Industries Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
- Predictive Oncology (NASDAQ:POAI) Shares Cross Below 200-Day Moving Average – Here’s What Happened
- Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure
- Predictive Oncology Inc. (POAI) Q3 2025 Earnings Call Prepared Remarks Transcript
Your note
Sign in to keep a note on POAI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHUNG-WELCH NANCY | Director | Stock Award(Grant) | Apr 4, 2024 | 21,237 |
| HANDLEY DANIEL E | Director | Stock Award(Grant) | Apr 4, 2024 | 18,661 |
| HAWRYLUK MATTHEW | Director | Stock Award(Grant) | Apr 4, 2024 | 9,488 |
| MYERS ROBERT L | Chief Financial Officer | Conversion of Exercise of derivative security | Sep 24, 2023 | 4,720 |
| NUZUM CHARLES LEE SR | Director | Stock Award(Grant) | Apr 4, 2024 | 31,921 |
| RAO VEENA | Director | Stock Award(Grant) | Apr 4, 2024 | 9,117 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.07% | 71,307 | 48.92K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.78% | 51,868 | 35.58K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 0.22% | 14,948 | 10.25K | Sep 29, 2024 |
| State Street Corporation | 0.21% | 13,837 | 9.49K | Sep 29, 2024 |
| Csenge Advisory Group | 0.19% | 13,000 | 8.92K | Sep 29, 2024 |
| Two Sigma Investments, LP | 0.19% | 12,560 | 8.62K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.05% | 69,881 | 47.94K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.52% | 34,894 | 23.94K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.14% | 9,279 | 6.37K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.06% | 3,782 | 2.59K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 2,138 | 1.47K | Oct 30, 2024 |